Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tumor necrosis factor a inhibitor therapy and cancer risk in chronic immune-mediated diseases.

Tumor necrosis factor a inhibitor therapy and cancer risk in chronic immune-mediated diseases. Arthritis Rheum. 2013 Jan; 65(1):48-58.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.